https://www.linkedin.com/in/miyu-ueno-smc/rec...ivity/all/
Quote:Miyu Ueno
Vice President at SMC Group International, Inc. | MASH-HCC, Inflammation, Fibrosis, Cancer, Immuno-oncologyVice President at SMC Group International, Inc. | MASH-HCC, Inflammation, Fibrosis, Cancer, Immuno-oncology
5 days ago • Visible to anyone on or off LinkedIn
Quote:We are pleased to announce that a collaborative research paper with hashtag#CytoDyn, a U.S.-based biotechnology company, has been published in the Journal of hashtag#Liver.
Title: “Leronlimab, a humanized anti-CCR5 monoclonal antibody ameliorates hepatic fibrosis in two preclinical fibrosis mouse models”
This study evaluated the anti-fibrotic effects of Leronlimab, a humanized anti-CCR5 monoclonal antibody, using two preclinical mouse models of hepatic hashtag#fibrosis. SMC Laboratories contributed to the in vivo pharmacology studies and pathological analyses conducted in this research.
Quote:Here is the link for full article.
https://lnkd.in/gpVKFrnH
Don't forget to open the link for the full research article